aromatase inhibitor with ovarian suppression
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for aromatase inhibitor with ovarian suppression, covering 2020-03-11 to 2020-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients [Phase 3]